Literature DB >> 16411221

Second and third malignant solid tumor in a girl with ovarian Sertoli-Leydig tumor.

John P Panagiotou1, Sophia Polychronopoulou, Kalliopi Sofou, Catherine Vanvliet-Constantinidou, Evangelos Papandreou, Stavros Haidas.   

Abstract

We report a Sertoli-Leydig cell (SLC) tumor of the right ovary in a 10-year-old girl, which was dealt with surgical removal. Three months after resection, she presented with a new episode of acute abdomen because of an abdominal mass, which histologically was compatible with an undifferentiated embryonal rhabdomyosarcoma. Chemotherapy, according to SIOP-??? 89 protocol, was administered additionally to radiotherapy (3,960 cGy). Three years after completing treatment, the patient developed a painful swelling at her left upper arm. The diagnosis was Ewing sarcoma of the humerus, which was confirmed by identification of the typical 11; 22 translocation on cytogenetic and molecular analysis of the tumor tissue. The patient died 14 months from Ewing diagnosis due to progressive disease.

Entities:  

Mesh:

Year:  2006        PMID: 16411221     DOI: 10.1002/pbc.20486

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  4 in total

1.  Embryonal rhabdomyosarcoma of the uterine cervix: a report of 14 cases and a discussion of its unusual clinicopathological associations.

Authors:  Louis P Dehner; Jason A Jarzembowski; D Ashley Hill
Journal:  Mod Pathol       Date:  2011-12-09       Impact factor: 7.842

2.  Sertoli-Leydig cell tumours of the ovary and testis: a CGH and FISH study.

Authors:  I Verdorfer; D Horst; A Höllrigl; H Rogatsch; G Mikuz
Journal:  Virchows Arch       Date:  2007-01-18       Impact factor: 4.064

3.  Sertoli-Leydig Cell Tumor with Concurrent Rhabdomyosarcoma: Three Case Reports and a Review of the Literature.

Authors:  Trisha Plastini; Arthur Staddon
Journal:  Case Rep Med       Date:  2017-07-02

Review 4.  DICER1 Syndrome and Cancer Predisposition: From a Rare Pediatric Tumor to Lifetime Risk.

Authors:  Anna Maria Caroleo; Maria Antonietta De Ioris; Luigi Boccuto; Iside Alessi; Giada Del Baldo; Antonella Cacchione; Emanuele Agolini; Martina Rinelli; Annalisa Serra; Andrea Carai; Angela Mastronuzzi
Journal:  Front Oncol       Date:  2021-01-21       Impact factor: 6.244

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.